Effects of the Spinal Manipulative Therapy and Myofascial Release in Individuals With Non-specific Chronic Low Back Pain
ChiroRCT
1 other identifier
interventional
90
1 country
1
Brief Summary
The aim will be to compare a experimental group submitted to a protocol of spinal manipulation and myofascial release; and a control group composed by spinal manipulation only, in individuals with chronic non-specific low back pain. This is a randomized controlled trial, characterized by the application of manual therapy, in two modalities: spinal manipulation plus myofascial release and spinal manipulation alone. Participants will be enrolled and randomly allocated into two groups: 1) spinal manipulation plus myofascial release, totaling 6 sessions, 2x/week, for 3 weeks; 2) spinal manipulation: 6 sessions, 2x/week, for 3 weeks. Participants will be evaluated in two different moments: 1) Baseline (pre-intervention); 2) at the end of intervention period (3 weeks); and 3) after 3 months follow-up. The primary outcomes will be pain intensity (measured in centimeters with the visual analogue scale - VAS) and disability (measured by the Quebec questionnaire - QDS). The secondary outcomes will be muscle fatigue (measured by the Biering-Sorensen test), postural balance (measured by the Y Balance test), pain threshold (algometry, in kgf) and perception of recovery (Likert scale of 6-points) and health status (measured by the Eq5d3L questionnaire). Data analysis will be performed with the SPSS (Statistical Package for the Social Sciences) software version 24.0. Data normality assumptions will be confirmed by the Shapiro Wilk test. If the assumptions were met, a mixed ANOVA with repeated measures will be adopted, based on the outcomes and the independent variables (groups), for the comparison between pre-intervention and post-intervention. Spinal manipulation plus myofascial release is expected to have better effects than spinal manipulation alone, associated with the outcomes of interest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2018
CompletedStudy Start
First participant enrolled
February 8, 2018
CompletedFirst Posted
Study publicly available on registry
February 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 17, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 17, 2018
CompletedNovember 27, 2018
November 1, 2018
7 months
February 8, 2018
November 24, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain intensity
Pain intensity measured by a Visual Analog Scale (in centimeters)
Change from Pre-Intervention (baseline) compared to Post-Intervention (3 weeks) and Follow up (3 months)
Disability
Quebec Back Pain Disability Scale (scores ranging from 0 to 100)
Change from Pre-Intervention (baseline) compared to Post-Intervention (3 weeks) and Follow up (3 months)
Secondary Outcomes (5)
Muscle fatigue
Change from Pre-Intervention (baseline) compared to Post-Intervention (3 weeks) and Follow up (3 months)
Health Status
Change from Pre-Intervention (baseline) compared to Post-Intervention (3 weeks) and Follow up (3 months)
Balance
Change from Pre-Intervention (baseline) compared to Post-Intervention (3 weeks) and Follow up (3 months)
Perception of Recovery
Change from Pre-Intervention (baseline) compared to Post-Intervention (3 weeks) and Follow up (3 months)
Pain threshold
Change from Pre-Intervention (baseline) compared to Post-Intervention (3 weeks) and Follow up (3 months)
Study Arms (2)
Spinal manipulation/myofascial release
EXPERIMENTAL2x/week, for 3 weeks, performed by a chiropractor. Sessions will last 20 minutes, with 1 individual per session. Myofascial release will be done on paravertebral muscle (Erector spinae, quadratus lumborum) and on gluteus maximus and piriform muscles, the pressure will depend of pain tolerance of each subject. After this procedure, the spinal manipulation will be performed on the sacroiliac join and on the lumbar vertebrae with less mobility.
Spinal manipulation
ACTIVE COMPARATOR2x/week, for 3 weeks, performed by a chiropractor. Sessions will last 20 minutes, with 1 individual per session. The spinal manipulation will be performed on the sacroiliac join and on the lumbar vertebrae with less mobility.
Interventions
The protocol will be composed by myofascial release followed by spinal manipulation. Paravertebral muscles and gluteus maximus and piriform muscles will be manually checked for tension, stiffness, spasm and painful points. The intervention will be composed by: trigger points release, release of muscle fascia and active release technique. The myofacial release will be done with a constant pressure during 30 seconds, 3x in each point. After this procedure, the spinal manipulation will be performed in high velocity and low amplitude thrust technique, on the lumbar spine and sacroiliac joint.
The sacroiliac joint will be test and manually verified for any dysfunction, and the lumbar spine will be also assessed to verify any hypomobility and vertebral rotation. The segments with alterations will be manipulated with a high velocity and low amplitude thrust technique.
Eligibility Criteria
You may qualify if:
- presence of non-specific chronic low back pain for more than 12 consecutive weeks;
- have not performed Physical Therapy, Osteopathic and/or chiropractic sessions for at least 3 months prior to the research.
You may not qualify if:
- history of trauma or fractures in the trunk and lumbar spine;
- presence of neural root symptoms;
- infection and inflammation on spine and upper and lower limbs for at least 3 months prior to research;
- have undergone surgery on spine, chest and abdomen;
- rheumatologic and myopathic diseases;
- renal, digestion and neurological diseases;
- use of anti-inflammatories drugs and analgesic drugs for at least 2 weeks prior the research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Complexo da Academia do Bombeiro Militar DF
BrasÃlia, Federal District, 70602-900, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rodrigo Carregaro, PhD
University of Brasilia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor won't have any knowledge about the study purposes and will be unaware of the group allocation. The statistical analysis will also be performed blinded for group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
February 8, 2018
First Posted
February 15, 2018
Study Start
February 8, 2018
Primary Completion
September 17, 2018
Study Completion
September 17, 2018
Last Updated
November 27, 2018
Record last verified: 2018-11